Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder feedback

Shareholder feedback

posted on Jan 14, 2009 05:34AM

Many great posts these last few days. My thanks to all contributors. I have been waiting for the CC since RG announced it at the SHM. One important thing that I remember him saying at the meeting was that the CC was a trial idea, an experiment. And that he would be looking for feedback from shareholders to determine if it would become a regular program. I thought it worked well. I hope that it does become a regular program of the company. I would incourage all others who thought likewise to let RG and management know your opinions. GLTAL

Share
New Message
Please login to post a reply